Cardiovascular disease in women: Gender-specific aspects of hypertension and the consequences of treatment

Marianne J. Legato

Research output: Contribution to journalArticle

Abstract

The epidemiology, clinical course, response to treatment, and ultimate outcome of essential hypertension vary as a function of gender. Three early trials on hypertension reported an increase in all-cause mortality in treated white women compared with black women or with men of both races. Later studies, however, suggest that drug therapy has similar and beneficial effects in hypertensive men and women. Women may tolerate hypertension better than do men. Diastolic hypertension correlates with higher mortality from coronary artery disease in men than in women. Special considerations apply to treating the hypertensive woman. Use of oral contraceptives may precipitate or accentuate the problem. In contrast, in the post-menopausal female, estrogen replacement may actually improve hypertension, via several mechanisms. These include the impact of the hormone on vasomotricity, its enhancement of baroreceptor sensitivity, and its impact on the hyperinsulinemia characteristic of menopause. Treatment of hypertension must be individualized with respect to gender. More data on the consequences of treatment of women with hypertension are needed, particularly longterm studies to assess the impact of treatment on mortality.

Original languageEnglish (US)
Pages (from-to)199-209
Number of pages11
JournalJournal of Women's Health
Volume7
Issue number2
StatePublished - 1998
Externally publishedYes

Fingerprint

Cardiovascular Diseases
Hypertension
Therapeutics
Mortality
Pressoreceptors
Estrogen Replacement Therapy
Hyperinsulinism
Oral Contraceptives
Menopause
Coronary Artery Disease
Epidemiology
Hormones
Drug Therapy

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Cardiovascular disease in women : Gender-specific aspects of hypertension and the consequences of treatment. / Legato, Marianne J.

In: Journal of Women's Health, Vol. 7, No. 2, 1998, p. 199-209.

Research output: Contribution to journalArticle

@article{5343220546224fa4a87c109db9659239,
title = "Cardiovascular disease in women: Gender-specific aspects of hypertension and the consequences of treatment",
abstract = "The epidemiology, clinical course, response to treatment, and ultimate outcome of essential hypertension vary as a function of gender. Three early trials on hypertension reported an increase in all-cause mortality in treated white women compared with black women or with men of both races. Later studies, however, suggest that drug therapy has similar and beneficial effects in hypertensive men and women. Women may tolerate hypertension better than do men. Diastolic hypertension correlates with higher mortality from coronary artery disease in men than in women. Special considerations apply to treating the hypertensive woman. Use of oral contraceptives may precipitate or accentuate the problem. In contrast, in the post-menopausal female, estrogen replacement may actually improve hypertension, via several mechanisms. These include the impact of the hormone on vasomotricity, its enhancement of baroreceptor sensitivity, and its impact on the hyperinsulinemia characteristic of menopause. Treatment of hypertension must be individualized with respect to gender. More data on the consequences of treatment of women with hypertension are needed, particularly longterm studies to assess the impact of treatment on mortality.",
author = "Legato, {Marianne J.}",
year = "1998",
language = "English (US)",
volume = "7",
pages = "199--209",
journal = "Journal of Women's Health",
issn = "1540-9996",
publisher = "Mary Ann Liebert Inc.",
number = "2",

}

TY - JOUR

T1 - Cardiovascular disease in women

T2 - Gender-specific aspects of hypertension and the consequences of treatment

AU - Legato, Marianne J.

PY - 1998

Y1 - 1998

N2 - The epidemiology, clinical course, response to treatment, and ultimate outcome of essential hypertension vary as a function of gender. Three early trials on hypertension reported an increase in all-cause mortality in treated white women compared with black women or with men of both races. Later studies, however, suggest that drug therapy has similar and beneficial effects in hypertensive men and women. Women may tolerate hypertension better than do men. Diastolic hypertension correlates with higher mortality from coronary artery disease in men than in women. Special considerations apply to treating the hypertensive woman. Use of oral contraceptives may precipitate or accentuate the problem. In contrast, in the post-menopausal female, estrogen replacement may actually improve hypertension, via several mechanisms. These include the impact of the hormone on vasomotricity, its enhancement of baroreceptor sensitivity, and its impact on the hyperinsulinemia characteristic of menopause. Treatment of hypertension must be individualized with respect to gender. More data on the consequences of treatment of women with hypertension are needed, particularly longterm studies to assess the impact of treatment on mortality.

AB - The epidemiology, clinical course, response to treatment, and ultimate outcome of essential hypertension vary as a function of gender. Three early trials on hypertension reported an increase in all-cause mortality in treated white women compared with black women or with men of both races. Later studies, however, suggest that drug therapy has similar and beneficial effects in hypertensive men and women. Women may tolerate hypertension better than do men. Diastolic hypertension correlates with higher mortality from coronary artery disease in men than in women. Special considerations apply to treating the hypertensive woman. Use of oral contraceptives may precipitate or accentuate the problem. In contrast, in the post-menopausal female, estrogen replacement may actually improve hypertension, via several mechanisms. These include the impact of the hormone on vasomotricity, its enhancement of baroreceptor sensitivity, and its impact on the hyperinsulinemia characteristic of menopause. Treatment of hypertension must be individualized with respect to gender. More data on the consequences of treatment of women with hypertension are needed, particularly longterm studies to assess the impact of treatment on mortality.

UR - http://www.scopus.com/inward/record.url?scp=37849185613&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=37849185613&partnerID=8YFLogxK

M3 - Article

VL - 7

SP - 199

EP - 209

JO - Journal of Women's Health

JF - Journal of Women's Health

SN - 1540-9996

IS - 2

ER -